AFYREN announces its 2025 half-year financial results
Clermont-Ferrand/Lyon, September 11, 2025, 07h30 CEST – AFYREN, a greentech company that offers manufacturers natural, low-carbon ingredients produced using unique fermentation technology based on a completely circular model, today announced financial results for the half-year ended June 30, 2025, which have been subject to a limited review by the statutory auditor and approved by the Board of Directors on September 10, 2025.
Continuous production and acceleration in commercialization
- Industrial continuous running of the plant achieved, and hundreds of tons of bio-based acids produced
- Over 100 tons already commercialized for several clients and applications
Good control of expenses and solid financial position
- Stable cash consumption in H1 2025 vs. 2024, including plant start-up financial support
- Solid cash position of € 27.5 million as of June 30, 2025
Short- and medium-term outlook
- First significant production revenue starting in 2025, plant breakeven (positive current EBITDA) within a few quarters
- Plant optimization program initiated
Nicolas SORDET, CEO of AFYREN, stated: “In the first half of 2025, we reached a key milestone in AFYREN’s history with the launch of continuous production, reflecting major operational progress. This advancement was accompanied by strong financial discipline, with cash consumption remaining stable compared to the same period last year. Looking ahead, our roadmap is clear: ramp up industrial output, accelerate the commercialization of our acids, and continue optimization work at the plant to meet European market expectations swiftly. The experience gained over the past two years is a valuable asset in achieving our global ambition, while maintaining strict budgetary discipline.”
The 2025 Half-year Financial Report is available today on the page: https://afyren.com/en/investors/#documentation
To read the full press release :
Last news
AFYREN receives €4 million in grants for AFYREN NEOXY and starts new performance-driven investment strategy
Press release
AFYREN begins new phase of industrial strategy as first plant AFYREN NEOXY achieves continuous production
Press release Availability of preparatory documents for the Combined General Meeting on June 17, 2025
Press release
AFYREN achieves “Responsible Care® Confirmed Diagnosis” certification and publishes its second sustainability report
Press release
AFYREN and Südzucker celebrate 5 years of strategic bioeconomy partnership
Press release AFYREN strengthens its Executive Committee with appointment of Laurent Pou as Industrial Director
Press release